Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir? therapy: A case report

摘要

Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir? as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression‐free survival are good.